Therapeutisches Mittel oder Prophylaktisches Mittel für das Trockene Auge

Details

Veröffentlichungs-Nr.

EP4751724

Anmeldetag

10. Juni 2024

Veröffentlichung

30. Januar 2025

Rechtsraum

EP

Abstract

The present invention aims to provide a novel agent for treating or preventing dry eye, an agent for treating or preventing graft-versus-host disease, an agent for promoting healing of corneal epithelial wound, an agent for suppressing an inflammatory cell infiltrating into the cornea, a tear volume retaining agent, an agent for suppressing a corneal epithelial damage, an agent for suppressing a cell positive for a cell proliferation marker, or an agent for suppressing differentiation of a lymphocyte into an effector T cell. The present invention provides a novel agent for treating or preventing dry eye, an agent for treating or preventing graft-versus-host disease, an agent for promoting healing of corneal epithelial wound, an agent for suppressing an inflammatory cell infiltrating into the cornea, a tear volume retaining agent, an agent for suppressing a corneal epithelial damage, an agent for suppressing a cell positive for a cell proliferation marker, or an agent for suppressing differentiation of a lymphocyte into an effector T cell, the agent comprising a substance derived from a culture supernatant of a stem cell as an active ingredient.

Anmelder

Firmen

U-Factor Co., Ltd.
Keio University

Land

🇯🇵 Japan